Insight Pharma Reports
Menu
  1. Home
  2. Therapeutic Indications
  3. Infectious Disease

Infectious Disease

Picture of Analytics of the Microbiome Landscape
Analytics of the Microbiome Landscape

NEW 2020 Report

From $7,000.00

Picture of Digital Health and the Management of Chronic Disease
Digital Health and the Management of Chronic Disease

New 2020 Report

From $3,295.00

Picture of COVID-19: A Major Review of How to Protect the Entire Pharma Supply Chain
COVID-19: A Major Review of How to Protect the Entire Pharma Supply Chain

New June 2020 Report

From $2,500.00

Picture of COVID-19 Implications for pharma: US payer insights
COVID-19 Implications for pharma: US payer insights

New June 2020 Report

From $1,195.00

Picture of Biopharmaceutical Venture Capital Trends: Coronavirus Disease (COVID-19) Company Impact Report
Biopharmaceutical Venture Capital Trends: Coronavirus Disease (COVID-19) Company Impact Report

New 2020 Report

From $695.00

Picture of Social Media: Coronavirus Disease (COVID-19) Sector Impact
Social Media: Coronavirus Disease (COVID-19) Sector Impact

New April 2020 Report

From $846.00

Picture of Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H1 2020
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H1 2020

New 2020 Report

From $2,500.00

Picture of Coronavirus outbreak: Impact on complex global supply chains and beyond
Coronavirus outbreak: Impact on complex global supply chains and beyond

New 2020 Report

From $846.00

Picture of COVID-19: Analysis of the Emerging Disease Landscape
COVID-19: Analysis of the Emerging Disease Landscape

2020 New Report

From $2,495.00

Picture of Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast
Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast

March 2020

From $1,995.00

Picture of Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast
Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast

March 2020

From $1,995.00

Picture of 2020 Global Respiratory Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
2020 Global Respiratory Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

2020 New Report

From $7,500.00

Picture of 2020 Global Coronavirus Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
2020 Global Coronavirus Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

2020 NEW REPORT

From $3,850.00

Picture of Global Antibiotics Partnering Terms and Agreements 2010 to 2020
Global Antibiotics Partnering Terms and Agreements 2010 to 2020

November 2020

From $3,495.00

Picture of 2016 Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products
2016 Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products

January 2017

From $3,850.00

Report Topics

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Copyright © 2023 Insight Pharma Reports. All rights reserved.
Powered by nopCommerce